Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Safety and Efficacy Results from the Open Label Extension of a Phase 2 Trial of Risankizumab, a Selective IL-23p19 Inhibitor in Patients with Active Psoriatic Arthritis

Kim A. Papp,Melinda Gooderham,Akimichi Morita,Alan J. Kivitz,Ranjeeta Sinvhal,Andrew S. Topp,Graham A. Heap,Ann Eldred,Philip J. Mease

ARTHRITIS & RHEUMATOLOGY（2019）

Cited 4|Views25
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined